Diageo plc (DEOP34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 27.54 |
|---|---|
| 52-week range | 20.82 – 29.37 |
| Return, 1 month / 3 months | +9.2% / +13.4% |
| Return, 1 year / 3 years | −2.5% / −27.6% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 42.8% |
| Worst drawdown (1 year) | -27.9% |
| Average daily value traded | 0.03M BRL |
| Dividend yield | 5.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Diageo is a drinks company based in London that makes and markets spirits, beer and wine. Its brands include Scotch whisky, vodka, gin, rum and stout, sold to retailers, bars, restaurants and distributors in many countries. The company also produces ready-to-drink beverages and operates through a network of regional sales and distribution businesses serving customers across the Americas, Europe, Africa and Asia.
Diageo plc is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code DEOP34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Diageo plc (DEOP34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 27.54 on 27 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 541 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.5% and over the last three months it rose 13.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.8% | ||
| From 52-week high | -5.5% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.4% | ||
| 6-month return | 25.2% | ||
| 12-month return, skipping the last month | -10.6% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.9% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M BRL | ||
| Zero-volume days | 1.7% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.2% |
|---|---|
| 1 month | +9.2% |
| 3 months | +13.4% |
| 6 months | +25.2% |
| 1 year | −2.5% |
| 3 years | −27.6% |
| 5 years | −49.7% |
Signals
| 50-day / 200-day average | 25.60 / 24.42 |
|---|---|
| Golden / death cross (60 days) | Golden, 42 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Apr 2026 | GBP 0.2091 |
| 15 Oct 2025 | GBP 0.7107 |
| 26 Feb 2025 | GBP 0.4852 |
| 28 Aug 2024 | GBP 0.7633 |
| 28 Feb 2024 | GBP 0.4538 |
| 23 Aug 2023 | GBP 0.6468 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.